Insider Trading › CBAY › Insiders
CBAY
CBAY·Insider activity
—
No end-of-day price on record
CBAY
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CBAYS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of CBAY were filed in the last 180 days. Newest filing Feb 14, 2024 (2 years ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by CBAY insiders · Form 4 · last two years
No open-market insider buys or sells in the last two years.
On Record
$0Purchases · 180 days
$0Sales · 180 days
136Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of CBAY common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
136 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Dorling JanetDirector | Sale | −6,000 | $31.97 | $192K | 0direct | Feb 12, 2024 | Feb 14, 2024 | Form 4 ↗ |
| McWherter CharlesPresident of R&D | Sale | −3,125 | $23.68 | $74K | 15.0Kdirect | Jan 19, 2024 | Jan 22, 2024 | Form 4 ↗ |
| McWherter CharlesPresident of R&D | Sale | −8,334 | $23.68 | $197K | 15.0Kdirect | Jan 19, 2024 | Jan 22, 2024 | Form 4 ↗ |
| McWherter CharlesPresident of R&D | Sale | −1,916 | $23.66 | $45K | 15.0Kdirect | Jan 19, 2024 | Jan 22, 2024 | Form 4 ↗ |
| McWherter CharlesPresident of R&D | Sale | −2,778 | $23.66 | $66K | 15.0Kdirect | Jan 19, 2024 | Jan 22, 2024 | Form 4 ↗ |
| McWherter CharlesPresident of R&D | Sale | −2,250 | $23.67 | $53K | 15.0Kdirect | Jan 19, 2024 | Jan 22, 2024 | Form 4 ↗ |
| Menold DanielVice President, Finance | Sale | −10.0K | $23.58 | $236K | 0direct | Jan 16, 2024 | Jan 16, 2024 | Form 4 ↗ |
| Quinlan Paul TGeneral Counsel | Sale | −5,000 | $23.58 | $118K | 0direct | Jan 16, 2024 | Jan 16, 2024 | Form 4 ↗ |
| Dorling JanetDirector | Sale | −6,000 | $23.86 | $143K | 0direct | Jan 10, 2024 | Jan 10, 2024 | Form 4 ↗ |
| McWherter CharlesPresident of R&D | Sale | −6,504 | $21.48 | $140K | 15.0Kdirect | Dec 18, 2023 | Dec 18, 2023 | Form 4 ↗ |
| McWherter CharlesPresident of R&D | Sale | −4,828 | $21.49 | $104K | 15.0Kdirect | Dec 18, 2023 | Dec 18, 2023 | Form 4 ↗ |
| Menold DanielVice President, Finance | Sale | −11.5K | $21.99 | $253K | 0direct | Dec 15, 2023 | Dec 15, 2023 | Form 4 ↗ |
| Menold DanielVice President, Finance | Sale | −10.0K | $21.98 | $220K | 0direct | Dec 15, 2023 | Dec 15, 2023 | Form 4 ↗ |
| Quinlan Paul TGeneral Counsel | Sale | −5,000 | $21.98 | $110K | 0direct | Dec 15, 2023 | Dec 15, 2023 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Sale | −890 | $20.81 | $19K | 171.3Kdirect | Dec 11, 2023 | Dec 11, 2023 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Sale | −64.0K | $19.99 | $1.3M | 171.3Kdirect | Dec 11, 2023 | Dec 11, 2023 | Form 4 ↗ |
| Dorling JanetDirector | Sale | −6,000 | $20.07 | $120K | 0direct | Dec 11, 2023 | Dec 11, 2023 | Form 4 ↗ |
| McWherter CharlesPresident of R&D | Sale | −11.3K | $18.28 | $207K | 15.0Kdirect | Nov 17, 2023 | Nov 17, 2023 | Form 4 ↗ |
| Menold DanielVice President, Finance | Sale | −0 | $17.38 | $0 | 0direct | Nov 15, 2023 | Nov 17, 2023 | Form 4 ↗ |
| Quinlan Paul TGeneral Counsel | Sale | −5,000 | $17.38 | $87K | 0direct | Nov 15, 2023 | Nov 17, 2023 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Sale | −20.9K | $15.89 | $331K | 171.3Kdirect | Nov 13, 2023 | Nov 14, 2023 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Sale | −44.0K | $15.89 | $699K | 171.3Kdirect | Nov 13, 2023 | Nov 14, 2023 | Form 4 ↗ |
| Dorling JanetDirector | Sale | −7,000 | $15.24 | $107K | 0direct | Nov 10, 2023 | Nov 14, 2023 | Form 4 ↗ |
| McWherter CharlesPresident of R&D | Sale | −21.7K | $14.07 | $306K | 15.0Kdirect | Oct 18, 2023 | Oct 18, 2023 | Form 4 ↗ |
| Menold DanielVice President, Finance | Sale | −0 | $13.76 | $0 | 0direct | Oct 16, 2023 | Oct 18, 2023 | Form 4 ↗ |
| Quinlan Paul TGeneral Counsel | Sale | −5,000 | $13.76 | $69K | 0direct | Oct 16, 2023 | Oct 18, 2023 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Sale | −64.9K | $14.20 | $921K | 171.3Kdirect | Oct 9, 2023 | Oct 10, 2023 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −15.9K | $15.68 | $250K | 90.0Kdirect | Sep 29, 2023 | Sep 29, 2023 | Form 4 ↗ |
| McWherter CharlesPresident of R&D | Sale | −21.7K | $16.22 | $353K | 15.0Kdirect | Sep 18, 2023 | Sep 19, 2023 | Form 4 ↗ |
| Menold DanielVice President, Finance | Sale | −0 | $16.87 | $0 | 0direct | Sep 15, 2023 | Sep 19, 2023 | Form 4 ↗ |
| Menold DanielVice President, Finance | Sale | −0 | $16.87 | $0 | 0direct | Sep 15, 2023 | Sep 19, 2023 | Form 4 ↗ |
| Quinlan Paul TGeneral Counsel | Sale | −24.0K | $16.87 | $405K | 0direct | Sep 15, 2023 | Sep 19, 2023 | Form 4 ↗ |
| Quinlan Paul TGeneral Counsel | Sale | −24.0K | $16.87 | $405K | 0direct | Sep 15, 2023 | Sep 19, 2023 | Form 4 ↗ |
| Quinlan Paul TGeneral Counsel | Sale | −5,000 | $16.87 | $84K | 0direct | Sep 15, 2023 | Sep 19, 2023 | Form 4 ↗ |
| McWherter CharlesPresident of R&D | Sale | −21.7K | $11.47 | $249K | 15.0Kdirect | Aug 18, 2023 | Aug 18, 2023 | Form 4 ↗ |
| Menold DanielVice President, Finance | Sale | −0 | $12.13 | $0 | 0direct | Aug 15, 2023 | Aug 16, 2023 | Form 4 ↗ |
| Menold DanielVice President, Finance | Sale | −0 | $11.92 | $0 | 0direct | Aug 15, 2023 | Aug 16, 2023 | Form 4 ↗ |
| Quinlan Paul TGeneral Counsel | Sale | −5,000 | $11.91 | $60K | 0direct | Aug 15, 2023 | Aug 16, 2023 | Form 4 ↗ |
| Menold DanielVice President, Finance | Sale | −20.9K | $12.35 | $259K | 0direct | Aug 9, 2023 | Aug 11, 2023 | Form 4 ↗ |
| McWherter CharlesPresident of R&D | Sale | −21.7K | $11.43 | $249K | 15.0Kdirect | Jul 18, 2023 | Jul 19, 2023 | Form 4 ↗ |
| Quinlan Paul TGeneral Counsel | Sale | −5,000 | $11.81 | $59K | 0direct | Jul 14, 2023 | Jul 14, 2023 | Form 4 ↗ |
| Quinlan Paul TGeneral Counsel | Sale | −5,000 | $10.05 | $50K | 0direct | Jun 30, 2023 | Jun 30, 2023 | Form 4 ↗ |
| McWherter CharlesPresident of R&D | Sale | −21.7K | $8.16 | $177K | 15.0Kdirect | Jun 20, 2023 | Jun 21, 2023 | Form 4 ↗ |
| McWherter CharlesPresident of R&D | Sale | −21.7K | $9.08 | $197K | 15.0Kdirect | May 18, 2023 | May 19, 2023 | Form 4 ↗ |
| Quinlan Paul TGeneral Counsel | Sale | −5,000 | $10.37 | $52K | 0direct | May 15, 2023 | May 17, 2023 | Form 4 ↗ |
| KIM DENNIS DChief Medical Officer | Sale | −112.2K | $9.54 | $1.1M | 20.0Kdirect | Apr 17, 2023 | Apr 17, 2023 | Form 4 ↗ |
| KIM DENNIS DChief Medical Officer | Sale | −7,781 | $8.98 | $70K | 20.0Kdirect | Apr 13, 2023 | Apr 17, 2023 | Form 4 ↗ |
| KIM DENNIS DChief Medical Officer | Sale | −100 | $8.99 | $899 | 20.0Kdirect | Mar 28, 2023 | Mar 30, 2023 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Purchase | +51.3K | $1.95 | $100K | 171.3Kdirect | Jun 6, 2022 | Jun 7, 2022 | Form 4 ↗ |
| KIM DENNIS DChief Medical Officer | Purchase | +20.0K | $3.04 | $61K | 20.0Kdirect | Jan 19, 2022 | Jan 20, 2022 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Purchase | +5,000 | $4.30 | $22K | 120.0Kdirect | Oct 10, 2019 | Oct 15, 2019 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Purchase | +3,100 | $5.55 | $17K | 115.0Kdirect | Sep 23, 2019 | Sep 24, 2019 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Purchase | +1,900 | $5.50 | $10K | 111.9Kdirect | Sep 20, 2019 | Sep 24, 2019 | Form 4 ↗ |
| GOLDFISCHER CARLDirector | Sale | −11.7K | $9.02 | $105K | 0direct | Feb 7, 2019 | Feb 8, 2019 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Purchase | +10.0K | $6.54 | $65K | 110.0Kdirect | Dec 21, 2018 | Dec 21, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −53.5K | $7.43 | $397K | 131.0Kindirect | Dec 18, 2018 | Dec 19, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −88.9K | $8.17 | $726K | 184.5Kindirect | Dec 17, 2018 | Dec 19, 2018 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Purchase | +5,000 | $9.90 | $50K | 100.0Kdirect | Oct 15, 2018 | Oct 16, 2018 | Form 4 ↗ |
| Menold DanielVice President, Finance | Sale | −5,000 | $13.00 | $65K | 0direct | Aug 29, 2018 | Aug 31, 2018 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Purchase | +5,000 | $10.90 | $55K | 95.0Kdirect | Jul 27, 2018 | Jul 30, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale Amended | −920 | $12.51 | $12K | 18.3Kindirect | Jun 5, 2018 | Jun 11, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −920 | $12.51 | $12K | 18.3Kindirect | Jun 5, 2018 | Jun 7, 2018 | Form 4 ↗ |
| Shah SujalChief Executive Officer · Director | Purchase | +5,000 | $10.65 | $53K | 90.0Kdirect | May 11, 2018 | May 15, 2018 | Form 4 ↗ |
| GOLDFISCHER CARLDirector | Sale | −15.0K | $13.03 | $195K | 0direct | Mar 22, 2018 | Mar 23, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −13.4K | $15.51 | $207K | 273.4Kindirect | Mar 5, 2018 | Mar 7, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −68.7K | $14.49 | $996K | 286.8Kindirect | Feb 15, 2018 | Feb 20, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale Amended | −163.0K | $13.69 | $2.2M | 355.5Kindirect | Feb 14, 2018 | Feb 16, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −163.0K | n/c | — | 355.5Kindirect | Feb 14, 2018 | Feb 15, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −55.1K | $13.51 | $744K | 518.5Kindirect | Feb 13, 2018 | Feb 15, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −40.8K | $12.35 | $503K | 419.7Kindirect | Feb 7, 2018 | Feb 9, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −18.8K | $12.14 | $229K | 460.5Kindirect | Feb 5, 2018 | Feb 7, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −2,000 | $12.11 | $24K | 479.3Kindirect | Feb 2, 2018 | Feb 5, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −88.1K | $12.15 | $1.1M | 481.3Kindirect | Feb 1, 2018 | Feb 5, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −12.3K | $12.23 | $150K | 569.4Kindirect | Jan 31, 2018 | Feb 1, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −85.3K | $12.22 | $1.0M | 581.7Kindirect | Jan 30, 2018 | Feb 1, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −39.4K | $12.18 | $480K | 667.0Kindirect | Jan 25, 2018 | Jan 26, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −138.3K | $10.40 | $1.4M | 706.5Kindirect | Jan 22, 2018 | Jan 24, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −130.6K | $10.25 | $1.3M | 844.7Kindirect | Jan 19, 2018 | Jan 22, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −13.6K | $10.21 | $139K | 975.3Kindirect | Jan 18, 2018 | Jan 22, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −4,300 | $10.21 | $44K | 988.9Kindirect | Jan 5, 2018 | Jan 9, 2018 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −173.2K | $9.41 | $1.6M | 993.2Kindirect | Dec 22, 2017 | Dec 27, 2017 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −50.0K | $9.26 | $463K | 1.2Mindirect | Nov 10, 2017 | Nov 14, 2017 | Form 4 ↗ |
| GOLDFISCHER CARLDirector | Sale | −18.0K | $8.66 | $156K | 0direct | Nov 2, 2017 | Nov 6, 2017 | Form 4 ↗ |
| McWherter CharlesSVP & Chief Scientific Officer | Purchase | +4,700 | $8.67 | $41K | 15.0Kdirect | Nov 2, 2017 | Nov 6, 2017 | Form 4 ↗ |
| McWherter CharlesSVP & Chief Scientific Officer | Purchase | +300 | $8.67 | $3K | 10.3Kdirect | Nov 2, 2017 | Nov 6, 2017 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −4,320 | $9.25 | $40K | 1.2Mindirect | Nov 1, 2017 | Nov 3, 2017 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −52.6K | $9.27 | $487K | 1.2Mindirect | Oct 31, 2017 | Nov 1, 2017 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −6,636 | $9.26 | $61K | 1.3Mindirect | Oct 30, 2017 | Nov 1, 2017 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −70.9K | $7.81 | $554K | 1.3Mindirect | Oct 3, 2017 | Oct 4, 2017 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −37.9K | $7.93 | $301K | 1.4Mindirect | Oct 2, 2017 | Oct 4, 2017 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −120.7K | $8.04 | $971K | 1.4Mindirect | Sep 29, 2017 | Oct 2, 2017 | Form 4 ↗ |
| EMSTER KURT VONDirector | Sale | −90.4K | $8.15 | $737K | 1.5Mindirect | Sep 28, 2017 | Oct 2, 2017 | Form 4 ↗ |
| Wills Robert JamesDirector | Purchase | +3,500 | $6.85 | $24K | 30.0Kdirect | Aug 1, 2017 | Aug 2, 2017 | Form 4 ↗ |
| Wills Robert JamesDirector | Purchase | +1,000 | $6.84 | $7K | 26.5Kdirect | Aug 1, 2017 | Aug 2, 2017 | Form 4 ↗ |
| Wills Robert JamesDirector | Purchase | +300 | $6.84 | $2K | 25.5Kdirect | Aug 1, 2017 | Aug 2, 2017 | Form 4 ↗ |
| Wills Robert JamesDirector | Purchase | +200 | $6.83 | $1K | 25.2Kdirect | Aug 1, 2017 | Aug 2, 2017 | Form 4 ↗ |
| McWherter CharlesSVP & Chief Scientific Officer | Purchase | +1,700 | $7.43 | $13K | 10.0Kdirect | Jul 20, 2017 | Jul 24, 2017 | Form 4 ↗ |
| McWherter CharlesSVP & Chief Scientific Officer | Purchase | +200 | $7.43 | $1K | 8,300direct | Jul 20, 2017 | Jul 24, 2017 | Form 4 ↗ |
| McWherter CharlesSVP & Chief Scientific Officer | Purchase | +3,000 | $7.43 | $22K | 8,100direct | Jul 20, 2017 | Jul 24, 2017 | Form 4 ↗ |
| McWherter CharlesSVP & Chief Scientific Officer | Purchase | +100 | $7.42 | $742 | 5,100direct | Jul 20, 2017 | Jul 24, 2017 | Form 4 ↗ |
| Shah SujalInterim President & CEO · Director | Purchase | +8,033 | $7.35 | $59K | 85.0Kdirect | Jul 20, 2017 | Jul 24, 2017 | Form 4 ↗ |
| Shah SujalInterim President & CEO · Director | Purchase | +100 | $7.32 | $732 | 77.0Kdirect | Jul 20, 2017 | Jul 24, 2017 | Form 4 ↗ |
| Shah SujalInterim President & CEO · Director | Purchase | +576 | $7.31 | $4K | 76.9Kdirect | Jul 20, 2017 | Jul 24, 2017 | Form 4 ↗ |
| Shah SujalInterim President & CEO · Director | Purchase | +400 | $7.30 | $3K | 76.3Kdirect | Jul 20, 2017 | Jul 24, 2017 | Form 4 ↗ |
| Shah SujalInterim President & CEO · Director | Purchase | +891 | $7.29 | $6K | 75.9Kdirect | Jul 20, 2017 | Jul 24, 2017 | Form 4 ↗ |
| EMSTER KURT VONDirector | Purchase | +153.8K | $6.50 | $1.0M | 1.8Mindirect | Jul 19, 2017 | Feb 12, 2018 | Form 4 ↗ |
| Wills Robert JamesDirector | Purchase | +25.0K | $2.43 | $61K | 25.0Kdirect | Sep 6, 2016 | Sep 9, 2016 | Form 4 ↗ |
| OMara Patrick J.VP, Business Development | Purchase | +5,000 | $1.64 | $8K | 5,022direct | Apr 15, 2016 | Apr 19, 2016 | Form 4 ↗ |
| McWherter CharlesSr. Vice President | Purchase | +3,000 | $1.68 | $5K | 5,000direct | Apr 15, 2016 | Apr 19, 2016 | Form 4 ↗ |
| Shah SujalChief Financial Officer | Purchase | +33.0K | $1.39 | $46K | 75.0Kdirect | Apr 5, 2016 | Apr 6, 2016 | Form 4 ↗ |
| Shah SujalChief Financial Officer | Purchase | +22.0K | $1.39 | $31K | 42.0Kdirect | Apr 4, 2016 | Apr 6, 2016 | Form 4 ↗ |
| GOLDFISCHER CARLDirector | Sale | −948 | $2.76 | $3K | 0indirect | Sep 11, 2015 | Sep 11, 2015 | Form 4 ↗ |
| GOLDFISCHER CARLDirector | Sale | −14.5K | $2.76 | $40K | 0indirect | Sep 11, 2015 | Sep 11, 2015 | Form 4 ↗ |
| GOLDFISCHER CARLDirector | Sale | −13 | $2.77 | $36 | 0indirect | Sep 11, 2015 | Sep 11, 2015 | Form 4 ↗ |
| GOLDFISCHER CARLDirector | Sale | −1,011 | $2.71 | $3K | 948indirect | Sep 10, 2015 | Sep 11, 2015 | Form 4 ↗ |
| GOLDFISCHER CARLDirector | Sale | −15.5K | $2.71 | $42K | 14.5Kindirect | Sep 10, 2015 | Sep 11, 2015 | Form 4 ↗ |
| GOLDFISCHER CARLDirector | Sale | −15 | $2.71 | $41 | 13indirect | Sep 10, 2015 | Sep 11, 2015 | Form 4 ↗ |
| GOLDFISCHER CARLDirector | Sale | −905 | $2.76 | $2K | 1,959indirect | Sep 9, 2015 | Sep 11, 2015 | Form 4 ↗ |
| GOLDFISCHER CARLDirector | Sale | −13.8K | $2.76 | $38K | 30.0Kindirect | Sep 9, 2015 | Sep 11, 2015 | Form 4 ↗ |
| GOLDFISCHER CARLDirector | Sale | −13 | $2.76 | $36 | 28indirect | Sep 9, 2015 | Sep 11, 2015 | Form 4 ↗ |
| von Emster KurtDirector | Purchase | +58.6K | $2.70 | $158K | 90.0Kdirect | Aug 14, 2015 | Aug 17, 2015 | Form 4 ↗ |
| von Emster KurtDirector | Purchase | +31.4K | $2.68 | $84K | 31.4Kdirect | Aug 13, 2015 | Aug 17, 2015 | Form 4 ↗ |
| von Emster KurtDirector | Purchase | +1.6M | $2.81 | $4.5M | 1.6Mindirect | Jul 20, 2015 | Jul 21, 2015 | Form 4 ↗ |
| Van Wart HaroldPresident and CEO · Director | Purchase | +100 | $3.28 | $328 | 7,958direct | May 18, 2015 | May 19, 2015 | Form 4 ↗ |
| Van Wart HaroldPresident and CEO · Director | Purchase | +100 | $3.29 | $329 | 7,858direct | May 18, 2015 | May 19, 2015 | Form 4 ↗ |
| Van Wart HaroldPresident and CEO · Director | Purchase | +7,300 | $3.34 | $24K | 7,758direct | May 18, 2015 | May 19, 2015 | Form 4 ↗ |
| Shah SujalChief Financial Officer | Purchase | +10.0K | $3.40 | $34K | 20.0Kdirect | May 18, 2015 | May 19, 2015 | Form 4 ↗ |
| McWherter CharlesSr. Vice President | Purchase | +1,000 | $3.16 | $3K | 2,000direct | May 15, 2015 | May 19, 2015 | Form 4 ↗ |
| McWherter CharlesSr. Vice President | Purchase | +600 | $3.17 | $2K | 1,000direct | May 15, 2015 | May 19, 2015 | Form 4 ↗ |
| McWherter CharlesSr. Vice President | Purchase | +400 | $3.14 | $1K | 400direct | May 15, 2015 | May 19, 2015 | Form 4 ↗ |
| CAL-BAY INTERNATIONAL INCPresident & CEO · Director · 10% owner | Purchase | +700.0M | $0.00 | $0 | 1.90Bdirect | Sep 24, 2007 | Sep 24, 2007 | Form 4 ↗ |
| CAL-BAY INTERNATIONAL INCPRESIDENT & CEO · Director · 10% owner | Purchase | +503.0M | $0.00 | $0 | 1.20Bdirect | Sep 21, 2007 | Sep 21, 2007 | Form 4 ↗ |
| CAL-BAY INTERNATIONAL INCPRESIDENT & CEO · Director · 10% owner | Purchase | +500.0M | $0.00 | $0 | 697.0Mdirect | Sep 20, 2007 | Sep 21, 2007 | Form 4 ↗ |
| CAL-BAY INTERNATIONAL INCPresident & CEO · Director · 10% owner | Purchase | +60.0M | $0.00 | $0 | 197.0Mdirect | Sep 19, 2007 | Sep 19, 2007 | Form 4 ↗ |
| CAL-BAY INTERNATIONAL INCDirector · 10% owner | Purchase | +100.0M | $0.00 | $0 | 137.0Mdirect | Sep 18, 2007 | Sep 18, 2007 | Form 4 ↗ |
| CAL-BAY INTERNATIONAL INC10% owner | Purchase | +37.0M | $0.00 | $0 | 37.0Mdirect | Sep 5, 2007 | Sep 6, 2007 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →